OPC-108459
269-13-001
Phase 1 small_molecule completed
Quick answer
OPC-108459 for Atrial Fibrillation is a Phase 1 program (small_molecule) at Otsuka Beijing Research Institute with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Otsuka Beijing Research Institute
- Indication
- Atrial Fibrillation
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed